Gaudium IVF and Women Health Ltd, a leading fertility services provider, has announced a price band of Rs 75-79 per share for its initial public offering (IPO). This move marks a significant milestone for the company as it aims to raise Rs 165 crore, making it the first in its sector to enter the public markets.
The proceeds from the fresh issue will be utilized for the establishment of 19 new IVF centers, debt repayments, and general corporate activities. Gaudium IVF plans to expand its services into underserved areas of India, capitalizing on the sector's growth potential.
Gaudium IVF, renowned for its pioneering role in assisted reproductive technologies, is poised to tap into the vast opportunities presented by the Indian fertility market. The sector is projected to grow at a 13% CAGR, making it an attractive space for market players.
The company's debut on stock exchanges is set for February 27, with Sarthi Capital Advisors leading the issue. This marks a significant step for Gaudium IVF as it enters the public markets, offering investors a chance to be a part of the company's growth journey.
